US2008306252A1PendingUtilityA1

Sulfonamido ether substituted imidazoquinolines

64
Assignee: COLEY PHARM GROUP INCPriority: Dec 8, 2000Filed: May 30, 2008Published: Dec 11, 2008
Est. expiryDec 8, 2020(expired)· nominal 20-yr term from priority
Inventors:Stephen L. CrooksGeorge W. GriesgraberPhilip D. HeppnerBryon A. MerrillRalph R. RobertsAi-Ping Wei
A61P 37/02A61P 31/12C07D 471/04
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims

exact text as granted — not AI-modified
1 .- 26 . (canceled) 
   
   
       27 . A compound selected from the group consisting of: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2008306252A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.